by Jordana Choucair | Nov 1, 2021 | Payers
Advocates across the aerospace, distribution, defense, and trucking sectors are concerned about companies being able to meet the federal government’s December 8 COVID-19 vaccine and difficulties the mandate could pose on their labor force. The American Trucking...
by Jordana Choucair | Nov 1, 2021 | Life Sciences
The FDA issued emergency use authorization on Friday for Pfizer’s Covid-19 vaccine for children 5 to 11 years old. The agency authorized a two-dose series of the vaccine, but with just one-third of the active ingredient compared to the adult dosage. The...
by Jordana Choucair | Nov 1, 2021 | D.C. News
Congressional Democrats are hoping to strike a deal as soon as today on adding prescription drug pricing measures to their social spending bill. The latest draft would allow Medicare to negotiate some drug prices and include a redesign of Medicare Part D and rebates,...
by Jordana Choucair | Nov 1, 2021 | Access & Coverage
Data from the National Health Interview Survey found that the rate of uninsured Americans in 2020 held steady between 8.6 percent and 9.7 percent, despite pandemic-related job losses and other economic challenges. Approximately 31.6 million people under age 65 were...
by Jordana Choucair | Oct 29, 2021 | D.C. News
The White House released a new framework outlining what will be in a $1.75 trillion spending package. The framework would extend enhanced ACA through 2025 and make ACA subsidies available to people in the Medicaid coverage gap in states that have chosen not to expand....
by Jordana Choucair | Oct 29, 2021 | D.C. News
Energy and Commerce Chairman Frank Pallone and Senate Finance Chairman Ron Wyden both told reporters that drug prices are still being discussed. According to Wyden, there is agreement on two pieces of the proposal – a rebate when drugmakers raise prices faster than...
Recent Comments